| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
35,791 |
33,611 |
$1.68M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,410 |
7,085 |
$231K |
| 99215 |
Prolong outpt/office vis |
3,251 |
3,045 |
$186K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,618 |
2,457 |
$173K |
| 95886 |
|
2,384 |
2,262 |
$100K |
| 64615 |
|
810 |
759 |
$66K |
| 99205 |
Prolong outpt/office vis |
715 |
683 |
$59K |
| 95911 |
|
499 |
467 |
$50K |
| 95816 |
|
974 |
915 |
$47K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
117 |
111 |
$25K |
| 99245 |
|
260 |
249 |
$24K |
| 95819 |
|
286 |
275 |
$15K |
| 99223 |
Prolong inpt eval add15 m |
272 |
256 |
$13K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
115 |
53 |
$9K |
| 95811 |
|
39 |
38 |
$9K |
| J0586 |
Injection, abobotulinumtoxina, 5 units |
22 |
12 |
$8K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
169 |
78 |
$8K |
| J1110 |
Injection, dihydroergotamine mesylate, per 1 mg |
81 |
38 |
$7K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
26 |
26 |
$6K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
76 |
75 |
$5K |
| 95909 |
|
73 |
67 |
$5K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
115 |
53 |
$4K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
68 |
51 |
$977.97 |
| 95991 |
|
18 |
18 |
$688.49 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
114 |
54 |
$681.57 |
| 99236 |
Prolong inpt eval add15 m |
12 |
12 |
$604.57 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
13 |
13 |
$447.05 |
| 99233 |
Prolong inpt eval add15 m |
18 |
12 |
$239.68 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
107 |
52 |
$237.41 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
113 |
54 |
$184.40 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
16 |
16 |
$173.80 |
| 95874 |
|
15 |
12 |
$128.76 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
4,884 |
4,574 |
$79.46 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
110 |
52 |
$71.84 |
| J2060 |
Injection, lorazepam, 2 mg |
88 |
39 |
$58.63 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
80 |
38 |
$38.99 |
| 94761 |
|
81 |
41 |
$11.30 |